Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studies
-
* Corresponding author: Peter M Wehmeier wehmeier_peter@lilly.com
Child and Adolescent Psychiatry and Mental Health 2009, 3:5 doi:10.1186/1753-2000-3-5
No comments have yet been made on this article.